ArticleAnimals : an open access journal from MDPI2026
Effects of Different Commercial Formulations of Tannic Acid Added at an Equal Inclusion Rate on Intestinal Health and Microbial Flora in Yellow-Feathered Broilers.
Article in Animals : an open access journal from MDPI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Antibiotic restrictions require safe alternatives. Tannic acid has antimicrobial and gut-regulatory properties, but data on its formulations are limited. This study employed an equal raw material inclusion design, adding three commercial tannic acid products at 250 mg/kg to compare their effects in yellow-feathered broilers. A total of 432 broilers were assigned to four groups: control, coated (LCTA), powdered (LPTA), or granular (LGTA) tannic acid. Growth performance did not differ among groups. LPTA numerically improved ADG and reduced serum urea, while LGTA increased triglycerides. LCTA enhanced CAT and SOD activities but also elevated MDA. All treatments reduced villus height, but LPTA improved VH/CD ratio.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.